Reply to: "Toxicity and dosimetry in SORAMIC study"
- PMID: 32653221
- DOI: 10.1016/j.jhep.2020.05.027
Reply to: "Toxicity and dosimetry in SORAMIC study"
Conflict of interest statement
Conflict of interest Jens Ricke, grants and personal fees from Sirtex Medical outside the submited work. Bruno Sangro, personal fees and non-financial support from Sirtex Medical, personal fees from BTG, personal fees from Bayer, personal fees and non-financial support from BMS, personal fees from Astra Zeneca, personal fees from Eli Lilly, personal fees from Merck, personal fees from Novartis, personal fees from Terumo, personal fees from Adaptimmune, outside the submitted work. Peter Malfertheiner, grants from Sirtex outside the submitted work. Max Seidensticker, personal fees from Sirtex Medical outside the submited work. Andrei Todica, personal fees from Sirtex Medical outside the submited work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.J Hepatol. 2019 Dec;71(6):1164-1174. doi: 10.1016/j.jhep.2019.08.006. Epub 2019 Aug 14. J Hepatol. 2019. PMID: 31421157 Clinical Trial.
-
Toxicity and dosimetry in SORAMIC study.J Hepatol. 2020 Sep;73(3):734-735. doi: 10.1016/j.jhep.2020.03.045. Epub 2020 Jul 1. J Hepatol. 2020. PMID: 32622664 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical